Cargando…

Effects of omalizumab on chronic urticaria not responding to recommended therapy

Detalles Bibliográficos
Autores principales:	Hébert, Jacques, Caron-Guay, Rose-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487808/ http://dx.doi.org/10.1186/1710-1492-8-S1-A17

Ejemplares similares

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012)

Omalizumab therapy in three patients with chronic autoimmune urticaria
por: Al-Ahmad, Mona
Publicado: (2010)

Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016)

281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012)

Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria
por: Nam, Young-Hee, et al.
Publicado: (2012)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

Thyroid dysfunction in patients with chronic urticaria
por: De Souza Lopes, Rita De Cássia, et al.
Publicado: (2015)

Efficacy and safety of omalizumab therapy in urticaria vasculitis
por: Petrelli, Fiorella, et al.
Publicado: (2022)

Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
por: Barrios, Jonathan Lacombe, et al.
Publicado: (2011)

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients
por: Dekkers, Coco, et al.
Publicado: (2021)

Cost‐effectiveness of personalized omalizumab dosing for chronic spontaneous urticaria
por: Denman, Sarah, et al.
Publicado: (2022)

Cytokine Profiles of Chronic Urticaria Patients and The Effect of Omalizumab Treatment
por: Can Bostan, Ozge, et al.
Publicado: (2023)

Childhood chronic urticaria and type 1 diabetes
por: Mazzetti, A, et al.
Publicado: (2011)

T cell activity in successful treatment of chronic urticaria with omalizumab
por: Sánchez-Machín, Inmaculada, et al.
Publicado: (2011)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

Expert consensus on the use of omalizumab in chronic urticaria in China()
por: Zhao, Zuotao, et al.
Publicado: (2021)

Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
por: Song, Xiaoting, et al.
Publicado: (2023)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

274 Vasculitic Urticaria Treated with Omalizumab. Case Report
por: Ramírez Del Pozo, María Elena, et al.
Publicado: (2012)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?()
por: Kocatürk, Emek, et al.
Publicado: (2022)

Chronic Spontaneous Urticaria – the Saskatchewan experience and questionnaire survey
por: Gattey, Natasha, et al.
Publicado: (2014)

Chronic urticaria: the first visit in a specialized unit
por: Machado Pereira, Camila Teles, et al.
Publicado: (2015)

Urticaria and angioedema as possible reactions of omalizumab
por: Ozbagcivan, Ozlem, et al.
Publicado: (2018)

Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
por: Ivyanskiy, Ilya, et al.
Publicado: (2012)

Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Omalizumab treatment for chronic spontaneous urticaria: data from Turkey
por: Kara, Rabia Oztas, et al.
Publicado: (2022)

The impact of home treatment and self-administration of omalizumab on chronic urticaria
por: Wiuff, Anne Christine, et al.
Publicado: (2022)

Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria
por: Pedersen, Nadja Højgaard, et al.
Publicado: (2023)

Is response to IVIG in Chronic Idiopathic Urticaria related to presense of autoantibodies?
por: Rosenfield, Lana, et al.
Publicado: (2014)

Quality of life and disease activity assessment in patients with chronic urticaria
por: Dias, Gabriela Andrade C, et al.
Publicado: (2015)

Prospective, monocentric, observational study of the long-term effectiveness of omalizumab in chronic urticaria
por: Traidl, Stephan, et al.
Publicado: (2023)

Allergic diseases of the skin and drug allergies – 2021. Efficacy of montelukast as add-on therapy in patients with chronic idiopathic urticaria
por: Khan, Sujoy, et al.
Publicado: (2013)

Measured depth of subcutaneous tissue on posterolateral arm of omalizumab patients
por: Potts, Ryan, et al.
Publicado: (2012)

Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
por: O’Quinn, John, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sl86nf1fthendtb41eldn3iv19